Tumor targeting properties of antibody fusion proteins based on different members of the murine tumor necrosis superfamily
Authors:
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Journal of Biotechnology
- Vol. 172, 73-76
Abstract
No abstract availableKeywords
Funding Information
- ETH Zurich
- Swiss National Science Foundation
- Kommission für Technologie und Innovation (KTI Medtech Award)
- European Union (FP7 Project PRIAT)
- Philochem AG
This publication has 29 references indexed in Scilit:
- Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patientsBritish Journal of Cancer, 2012
- Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivoMolecular Cancer, 2010
- Potent Systemic Anticancer Activity of Adenovirally Expressed EGFR-Selective TRAIL Fusion ProteinMolecular Therapy, 2008
- The TNF Superfamily-2008Cytokine & Growth Factor Reviews, 2008
- The clinical trail of TRAILEuropean Journal of Cancer, 2006
- Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic OriginClinical Cancer Research, 2006
- Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapyInternational Journal of Cancer, 2005
- Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFRJournal of Biological Chemistry, 2005
- Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted ActivationJournal of Biological Chemistry, 2003
- Tumor‐targeting properties of antibody–vascular endothelial growth factor fusion proteinsInternational Journal of Cancer, 2002